Steve Mandel

Steve Mandel

Last Update: 05-16-2016

Number of Stocks: 41
Number of New Stocks: 6

Total Value: $20,099 Mil
Q/Q Turnover: 14%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Steve Mandel Watch

  • Steve Mandel Buys Allergan, Baxalta, PayPal

    Steve Mandel (Trades, Portfolio), the founder of Lone Pine Capital, a long/short equity money manager, bought shares in the following stocks in the first quarter.


    The investor acquired 1,789,239 shares in Allergan PLC (AGN) with an impact of 2.39% on the portfolio.

      


  • Steve Mandel Buys Stake in Yum! Brands

    During the first quarter, Steve Mandel purchased 1,512,569 shares of Yum! Brands Inc. (NYSE:YUM).


    1689623493.png

      


  • Electronic Arts Is a Leading Growth Stock in Multimedia Technology

    Electronic Arts (NASDAQ:EA) reported its fourth quarter earnings on May 10 and the company has been steadily gaining since its earnings report, adding 17.5% to trade at $75.80. The stock’s growth follows a fourth quarter and year-end earnings report that showed 25% growth in earnings per share from 2015. For the year, EPS was $3.14, up from $2.51 in 2015.


      


  • High Quality Guru Stocks Include TransDigm, Chipotle

    According to GuruFocus’ All-in-One Screener, the following stocks have a high business predictability rating and at least five gurus are shareholders in the companies.


    TransDigm Group Inc. (TDG)

      


  • Time To Buy Allergan

    Allergan (NYSE:AGN) stock has dropped a lot because of rumors Pfizer (NYSE:PFE) will walk away from their deal.


    Pfizer made no attempt to pretend the deal was about anything but lowering its tax bill by relocating its headquarters to Ireland, Allergan’s homestead. The Irish tax rate compares favorably to the U.S. at 12.5%; when you are making billions in profits, it’s worth it to pay a couple of lawyers to figure it out. It seems the U.S. Treasury is now inventing new ways to apply rules just to spite Pfizer, and it looks like that’s working.

      


  • Top Insiders' Buys and Sales of the Week

    The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "March 2016."


    According to the above filters, the following are recent buys and sells from company insiders in the past week.

      


  • Steve Mandel Boosts Nike, Visa, Amazon

    Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long-short equity money manager, which he started in 1997. During the last quarter of 2015, he increased his stakes in many stocks, such as the as following:


    The investor raised his stake in Nike Inc. (NKE) by 101.66%, and the deal had an impact of 1.55% on the portfolio.

      


  • Steve Mandel Sells Health Care Stakes

    Steve Mandel (Trades, Portfolio), founder of Lone Pine Capital, sold out two health care stakes in the fourth quarter.


    Mandel’s most significant transaction in the fourth quarter was the sale of his 2,607,655-share stake in Allergan PLC (NYSE:AGN), a pharmaceutical company with offices in Dublin and New Jersey, for an average price of $298.52 per share. The divestiture had a -2.99% impact on Mandel’s portfolio.

      


  • Steve Mandel Ups Stake in Lululemon Athletica

    Guru Steve Mandel (Trades, Portfolio) graduated from Dartmouth College in 1978 and earned an MBA from Harvard Business School in 1982. Mandel landed his first job at Mars & Co., a global strategy consulting firm. In 1990, Mandel began to work for Julian Robertson (Trades, Portfolio)’s firm Tiger Management. Mandel worked alongside the legendary guru for seven years before founding his own investment firm Lone Pine Capital LLC in 1997. The firm was named after a pine tree that survived a lightning storm at Dartmouth. 


    In the first quarter of 2016, Steve Mandel (Trades, Portfolio) added 98,459 shares of Lululemon Athletica Inc. (NASDAQ:LULU)

      


  • Steve Mandel Sells Allergan, DaVita During 4th Quarter

    Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long/short equity money manager. During the fourth quarter Mandel sold many of his holdings.


    He exited his position in Allergan PLC (AGN) with an impact of -2.99% on the portfolio.

      


  • Steve Mandel Buys 8 New Stocks in 4th Quarter

    Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long/short equity money management firm he started in 1997. He manages a portfolio composed of 47 stocks, eight of which were new buys during the fourth quarter.


    The guru acquired 2,132,094 shares in Northrop Grumman Corp. (NOC), and the deal had an impact of 1.72% on the portfolio.

      


  • Lululemon: What Is Steve Mandel's Thesis?

    Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital. He has a terrific track record with his long/short equity portfolio, which began in 1997. Previously he was a senior managing director and consumer analyst at Tiger Management (1990 to 1997) under Julian Robertson (Trades, Portfolio) and a mass-market retailing analyst at Goldman Sachs (1984 to 1990). Lone Pine Capital got its name from a tree at Mandel’s alma mater that survived a lightning strike.


    Lone Pine Capital invests globally and goes both long and short to be ready for those lightning strikes. The company employs rigorous fundamental analysis. I’ve heard Baupost Group’s Seth Klarman (Trades, Portfolio) compliment him about his tremendously strong business specific research. Mandel isn’t a pure value guy as you’ll see, and tends to hold stocks for shorter time frames than most gurus.

      


  • Facebook, McDonald's Among Guru Stocks Outperforming S&P 500

    The following are some of the stocks that outperformed the S&P 500 Index over the last 12 months and have been bought by gurus during the last quarter.


    Facebook Inc. (FB) with a market cap of $327.41 billion, during the last 12 months has outperformed the S&P 500 Index by 55.7% and currently, 14 gurus are holding the stock that has returned 14% year-to-date and 205% during the last five years. It is now trading with a P/E ratio of 116.45 but according to the DCF calculator, it looks overpriced by 1,000%.

      


  • Mandel Takes 5% Stake in Athleisure Brand Lululemon

    Lone Pine Capital founder Steve Mandel (Trades, Portfolio) took a new stake in leading athleisure company Lululemon Athletica (NASDAQ:LULU) on Jan. 15, purchasing 6,446,607 shares at $55.71 each.


    Lululemon is well-known for ushering in the era of wearing yoga pants and workout clothing in life outside the gym. The company has inspired other high-end athletic wear brands that aim to compete in the industry. Lululemon’s stock is down 13% over the past year and up 5% year to date. As of Tuesday morning, it traded at 31x earnings.

      


  • Stocks in the Spotlight

    Stocks ended down on Monday as they came under heavy pressure toward the end of the trading day. Stocks once again followed crude lower, which settled at $30 after finishing last week at $31.


    News is starting to get interesting for energy stocks as the reality of $30 starts to set in. For example, Halliburton presented "an enhanced set of proposed divestitures" to the U.S. Department of Justice earlier this month. Halliburton also laid off 4,000 workers last year in an effort to cut costs down. In Canada, where the cost to produce a barrel of crude is much higher, some producers are losing money on every barrel they sell. Companies operating in the Canadian Oil Sands include Canadian Natural Resources (NYSE:CNQ), Suncor Energy (NYSE:SU), to which Warren Buffett keeps adding, and Imperial Oil (IMO).

      


  • Mandel, Cohen Bet Big on Electronic Arts

    Guru Steve Mandel (Trades, Portfolio) graduated from Dartmouth College in 1978, and later graduated with an MBA from Harvard. Mandel has been involved with hedge funds since 1990, when he worked at the legendary Tiger Management. He then left Tiger Management and formed his own hedge fund Lone Pine Capital in 1997. Mandel has a net worth of $2.3 billion.


    In 2013, Forbes listed Mandel as one of the top 40 highest-earning hedge fund managers. 

      


  • Steve Mandel Closes Position in Lowe's

    Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long/short equity money manager that he started in 1997. The firm uses fundamental analysis and bottom up stock picking to build the portfolio. Mandel uses both value and growth methodologies, and does not hold many stocks for very long.


    The following are his largest closed positions during the third quarter.

      


  • Steve Mandel Acquires Stakes in Amazon.com and Constellation Brands

    In the past Steve Mandel (Trades, Portfolio) of Lone Pine Capital has shown a preference for investments in technology, health care and financial services. All were represented in Mandel’s largest third-quarter transactions.


    Mandel’s most noteworthy third-quarter deal was his purchase of a 1,937,002-share stake in Amazon.com Inc. (NASDAQ:AMZN), a Seattle-based ecommerce company, for an average price of $505.62 per share. The acquisition had a 4.18% impact on Mandel’s portfolio.

      


  • Steve Mandel Adds More Than 32 Million Shares of These 2 Holdings

    Guru Steve Mandel has recently been increasing his holdings of Dollar Tree Stores Inc. (NASDAQ:DLTR) and Williams Companies (NYSE:WMB).


    Mandel graduated from Dartmouth College in 1978, and later graduated with an MBA from Harvard University. Mandel has been managing hedge funds since 1990, when he was the manager of Tiger Management. He then left Tiger and formed his own hedge fund, Lone Pine Capital, in 1997. Mandel has a net worth of $2.3 billion, according to Forbes.com

      


  • Paul Tudor Jones' Top 3 Stocks Includes Facebook as the Top Growing Stock

    Paul Tudor Jones (Trades, Portfolio)' Tudor Investment Corp. disclosed an equity portfolio valued at some $2.96 billion at the end of the quarter Sept. 30. The equity portfolio is mainly invested in Finance (27%), Technology (25%) and Consumer Discretionary (11%) stocks.


    Among the 10 largest holdings from Tudor Investment’s equity portfolio (which comprises 31.3% of the total portfolio value), the top three positions are Facebook Inc. (NASDAQ:FB), NCR Corp. (NYSE:NCR) and Time Warner Cable Inc. (NYSE:TWC).

      


  • Julian Robertson Boosts His Stakes in JD.com, Netflix

    Julian Robertson (Trades, Portfolio) is considered the father of hedge funds. He launched his firm Tiger Management in 1980 with $8 million and turned it into more than $22 billion in the late 1990s.


    He manages a portfolio composed of 48 stocks with a total value of $708 million; the following are the largest trades he did during the second quarter.

      


  • American International Group One of Most Weighted Buys in Q2 2015

    The hedge fund American International Group (NYSE:AIG) in its last quarterly 13F reported a total value of its portfolio of $25 billion, with an increase of 2.94% since the previous quarter. During Q2 2015, the firm bought 341 new stocks and increased 1,794 of its existing stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Allergan PLC (AGN) with an impact of 0.20% on its portfolio.

      


  • Horizon Pharma Leads Stock Returns in Health Care Industry

    Horizon Pharma (NASDAQ:HZNP) is currently reporting triple-digit year-to-date and one-year stock returns. As of Aug. 24, the company has a year-to-date stock return of 124.98% and a one-year stock return of 198.97%.


    Recently the company has received a great deal of press for its acquisition attempt of Depomed (NASDAQ:DEPO). In July, Depomed rejected Horizon Pharma’s most recent offer for a takeover which valued the company at $33 per share. Depomed has been unwilling to enter into negotiations for a merger of the two companies, and in July amongst various negotiation attempts also enacted a poison pill plan which blocks any shareholder from owning more than 10% of the stock. Horizon Pharma continues to seek to negotiate with Depomed which has cited it potentially would be willing to merge with Horizon Pharma at a higher acquisition offering price.

      


  • Lowe’s Grows Revenue and Capitalizes on Housing Market Improvements

    Lowe’s Companies, Inc. (NYSE:LOW) reported its second-quarter earnings results on Aug. 19. The company’s quarterly results were slightly mixed as sales grew strongly while earnings fell just below expectations. The strong sales growth report followed a strong quarter in the housing market which has continued to be a catalyst for many large home goods stores.


    For the quarter the company reported revenue of $17.4 billion, net earnings of $1.1 billion and earnings per share of $1.20. Revenue beat analysts’ consensus estimate by $30 million while earnings per share missed the consensus expectation by $0.04. Top line revenue grew 4.5% for the quarter. Revenue for the first half of the year also reported steady growth up 4.9% to a total of $31.5 billion.

      


  • Weekly CEO Buys Highlights: SHLD, HTZ, PAGP, DEA, ATEN

    According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:


    Sears Holdings Corp.: CEO, 10% Owner Edward S. Lampert bought 277,252 shares

      


  • Charter Communications Reports Strong Revenue Growth for the Second Quarter

    Charter Communications, Inc. (NASDAQ:CHTR) is one of the largest telecommunications companies in the United States. Its primary services include cable television, internet and voice. On August 4 the company reported its second quarter 2015 earnings results. Revenue for the quarter was $2.43 billion. For the quarter the company reported a net loss of $122 million resulting in earnings per share of -$1.09.


    Charter Communications steadily grew revenue in the second quarter with a revenue growth rate of 7.6% from the comparable quarter. Revenue growth was led by the company’s Internet business segment which grew revenue 16.5% from the second quarter of 2014. Charter also saw double-digit revenue growth in its Commercial business segment up 14%. Additionally, revenue grew steadily in Video with a growth rate of 3.4%.

      


  • Ariel Capital Advisors bought Sanofi and Priceline in Q2 2015

    At the end of the second quarter of 2015, the hedge fund Ariel Capital Advisors reported a total value of its portfolio of $174,199,000 with an increase of 3.44% since the previous quarter.


    During the Q2 2015, the hedge fund bought 282 new stocks and increased 51 stakes. The following are the most heavily weighted buys of U.S. companies the hedge fund has done during that quarter.

      


  • Mastercard's Results Excluding Exchange Rate Effects

    Last year, I wrote an article about MasterCard, Inc. (NYSE:MA) after Bill Nygren (Trades, Portfolio), the portfolio manager of The Oakmark Fund, had taken a long position on it. At that time, we calculated that Mastercard had a trailing P/E ratio that indicated overvaluation, but our valuation method said the contrary. Since my recommendation, the company´s shares surged by 25% in a period lower than a year.


    Steve Mandel is the largest shareholder of the company but decreased by 36% his position to $1.12 billion with 12.97 million shares, according to the fund's latest filing in Q1. On the other hand, Andreas Halvorsen (Trades, Portfolio) upped his stake by 93% to 8.26 million shares.

      


  • Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma

    Steven Mandel’s hedge fund, Lone Pine Capital, on July 27 initiated a position in Horizon Pharma Plc (NASDAQ:HZNP), according to GuruFocus Real Time Picks.


    The purchase was for 8,353,668 shares, which represent 5.4% of the drug company.

      


  • Steve Mandel Adds to Stake in Charter Communications

    Steve Mandel (Trades, Portfolio), founder and manager of Lone Pine Capital, recently added enough shares to his stake in Charter Communications Inc (NASDAQ:CHTR), currently the third-largest cable operator in the United States, to make it one of his top 20 stakes by volume.


    On July 6, Mandel acquired 3,010,321 shares of the Connecticut-based cable telecommunications company, previously the 30th-largest stake in his portfolio, paying an average price of $174.07 per share. The purchase raised Mandel’s stake to 6,338,300 shares.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)